Clinical Trials Directory

Trials / Completed

CompletedNCT01649700

Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
1 (actual)
Sponsor
National Yang Ming Chiao Tung University · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The study is to investigate the efficacy and safety of autologous transplantation of adipose-derived mesenchymal stem cells in patients with the sequelae caused by severe brain injury.

Conditions

Interventions

TypeNameDescription
BIOLOGICALautologous adipose-derived mesenchymal stem cellsPatients will receive five infusions, one month apart, each comprising 5-7x10\^7 cells of autologous adipose-derived mesenchymal stem cells.

Timeline

Start date
2011-10-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-07-25
Last updated
2014-09-12

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01649700. Inclusion in this directory is not an endorsement.